Диссертация (1140154), страница 24
Текст из файла (страница 24)
Autoimmunity. 2008; 41:429–4233155. Levy W, Mozaffarian D, Linker D. The Seatle heart failure model-prediction ofsurvival in heart failure. Circulation. 2006;113:1424156.Li Y, Heuser JS, Cunningham LC et al. Mimicry and antibody-mediated cellsignaling in autoimmune myocarditis. J Immunol. 2006; 177:8234–8240157.Liang CS, Mao W, Liu J. Pro-apoptotic effects of anti-beta1-adrenergic receptorantibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum andthe prosurvival PI3K-Akt pathway.
Autoimmunity. 2008; 41:434–441158.Liao YH. Functional analysis of autoantibodies against ADP/ATP carrier fromdilated cardiomyopathy. Int J Cardiol 1996;54:165-169159.Lie JT. Myocarditis and endomyocardial biopsy in unexplained heart failure: adiagnosis in search of a disease. Ann Intern Med. 1988;109:525-528160.Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imagingcompared with EMB in patients with suspected myocarditis.
J Am Coll CardiolImg. 2012;5(5):513-524161.Magnani JW, Danik HJ, Dec Jr GW, et al. Survival in biopsy provenmyocarditis: a long-term retrospective analysis of the histopathologic, clinical,and hemodynamic predictors. Am Heart J 2006;151:463-470162.
Magnani J.W., Dec G.W. Myocarditis: Current Trends in Diagnosis andTreatment. Circulation 2006;113:876-890148163.Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonanceassessment of human myocarditis. Circulation.2004;109:1250–1258164.Maisch B. Autoreactivity to the cardiac myocyte, connective tissue and theextracellular matrix in heart disease and postcardiac injury. Springer SeminImmunopathol 1989;11:369-395165.Maisch B. The sarcolemma as antigen in the secondary immunopathogenesis ofmyopericarditis. Eur Heart J (Suppl J) 1987;8:155-165166.Maisch B, Bauer E, Cirsi M, Kochsiek K.
Cytolytic cross-reactive antibodiesdirected against the cardiac membrane and viral proteins in coxsackievirus B3and B4 myocarditis. Characterization and pathogenetic relevance. Circulation1993;87 Suppl 4:IV49-IV65167.Maisch B, Lotze U, Schneider J, Kochsiek K. Antibodies to human sinus nodein sick sinus syndrome. Pacing Clin Electrophysiol 1986;9:1101-1109168.Maisch B, Ristic AD, Hufnagel G, Pankuweit S.
Pathophysiology of viralmyocarditis: the role of humoral immune response. Cardiovasc Pathol 2002;11:112–122169.Maisch B, Schwab D, Bauer E, et al. Antimyolemmal antibodies in myocarditisin children. Eur Heart J (Suppl J) 1987;8:167-173170. Maisch B, Wedeking U, Kochsiek K. Quantitative assessment of antilamininantibodies in myocarditis and perimyocarditis. Eur Heart J (Suppl J) 1987;8:233235171.Mangin M, Mahrholdt H, Sechtem U. Diagnosis of myocarditis: description andassessment of available methods. Dtsch Med Wochenschr.
2006;131:1228–1234172.Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions andclassification of the cardiomyopathies: an American Heart Association ScientificStatement from the Council on Clinical Cardiology, Heart Failure andTransplantation Committee; Quality of Care and Outcomes Research andFunctional Genomics and Translational Biology Interdisciplinary WorkingGroups;andCouncil2006;113:1807-1816onEpidemiologyandPrevention.Circulation.149173.Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis.
Rapid diagnosis byPCR in children. Circulation 1994;90:330-339174.Mascaro-Blanco A, Alvarez K, Yu X et al. Consequences of unlocking thecardiac myosin molecule in human myocarditis and cardiomyopathies.Autoimmunity. 2008; 41:442–453175.Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatorymyocarditis assisted by endomyocardial biopsy. Am J Cardiol 1980;45:10371044176.Mason JW, O’Connell JB, Herskowitz A et al.A clinical trial ofimmunosuppressive therapy for myocarditis.
The Myocarditis Treatment TrialInvestigators. N Engl J Med. 1995;333:269 –275177. Matsumori A. Cytokines in myocarditis and dilated cardiomyopathy. Eur HeartJ 2002; 4 (suppl I):42–45178.Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res2005;96:144 –7179.Matsumori A, Yamada T, Sasayama S.
Antimyosin antibody imaging in clinicalmyocarditis and cardiomyopathy: principle and application. Int J Cardiol1996;54:183-190180.McCaffrey F.M., Braden D.S., Strong W.B. Sudden cardiac death in youngathletes: a rewiew. Am J Dis Child 1991;145:177 – 183181.Medau HJ. [Therapy of myo- and pericarditis]. [Article in German].
Med Welt.1972; 23(35): р. 1131-4182.Mendes LA, Dec GW, Picard MH, et al. Right ventricular dysfunction: anindependent predictor of adverse outcome in patients with myocarditis. Am HeartJ 1994;128:301-307183. Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditisrevisited: clinical and prognostic significance of electrocardiographic changes.Am Heart J 1992;124:455-467150184.Morgera T, Salvi A, Alberti E et al. Morphological findings in apparentlyidiopathic ventricular tachycardia. An echocardiographic haemodynamic andhistologic study.
Eur Heart J. 1985; 6(4): p. 323-34185.Murphy JG, Frantz RP. Endomyocardial Biopsy in Myocarditis. In: Cooper LT,ed. Myocarditis: From Bench to Bedside. Totowa, NJ: Humana Press; 2003:371–389186.Myocarditis. From Bench to Bedside. Ed. by L.T.Cooper. – New Yersey:Humana Press, 2003, 634 p.187. Nakashima H, Katayama T, Ishizaki M, et al. Q wave and non-Q wavemyocarditis with special reference to clinical significance. Jpn Heart J1998;39:763-774188. Nieminen MS, Heikkila J, Karjalainen J.
Echocardiography in acute infectiousmyocarditis: relation to clinical and electrocardiographic findings. Am J Cardiol1984;53:1331-1337189.Nigro G, Bastianon V, Colloridi V, et al. Human parvovirus B19 infection ininfancy associated with acute and chronic lymphocytic myocarditis and highcytokine levels: report of 3 cases and review. Clin Infect Dis 2000;31:65-69190.Nippoldt TB, Edwards WD, Holmes DR Jr et al. Right ventricularendomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients.Mayo Clin Proc 1982;57:407-418191.Noda S.
Histopathology of endomyocardial biopsies from patients withidiopathic cardiomyopathy; quantitative evaluation based on multivariatestatistical analysis. Jpn Circ J 1980;44:95-116192.Norja P, Eis-Hübinger AM, Söderlund-Venermo M, et al.
Rapid sequencechange and geographical spread of human parvovirus B19: comparison of B19virus evolution in acute and persistent infections. J Virol 2008; 82:6427193.Norja P, Hokynar K, Aaltonen LM, et al. Bioportfolio: Lifelong persistence ofvariant and prototypic erythrovirus DNA genomes in human tissue. Proc NatlAcad Sci U S A. 2006;103:7450–53151194.Nussinovitch U, ShoenfeldY. Autoimmunity and heart diseases: pathogenesisand diagnostic criteria. Arch Immunol.
Ther. Exp. 2009; 57:95-104195.Nussinovitch U, Shoenfeld Y. The clinical and diagnostic significance of antimyosin autoantibodies in cardiac disease. Clin Rev Allergy Immunol.2013;44:98-108196.Nussinovitch U, Shoenfeld Y. The clinical significance of anti-beta-1 adrenergicreceptor autoantibodies in cardiac disease. Clin Rev Allergy Immunol.
2010 Dec29.197.Oakes DF, Manolis AS, Estes NA. Limited clinical utility of endomyocardialbiopsy in patients presenting with ventricular tachycardia without apparentstructural heart disease. Clin Cardiol. 1992; 15(1): р. 24-8, 499198.O'Connell JB, Henkin RE, Robinson JA et al. Gallium-67 imaging in patientswith dilated cardiomyopathy and biopsy-proven myocarditis.
Circulation. 1984;70(1): р. 58-62199. O’Connell JB, Robinson JA, Henkin RE, Gunnar RM. Immunosuppressivetherapy in patients with congestive cardiomyopathy and myocardial uptake ofgallium-67. Circulation. 1981;64:780-786200.Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditisassociated with hepatitis C virus infection.
Circulation 1997;96:22-24201.Ong P, Athansiadis A, Hill S et al. Usefulness of pericardial effusion as newdiagnostic criterion for noninvasive detection of myocarditis. Am J Cardiol.2011; 108(3): p. 445-52202.Padalko E, Ohnishi T, Matsushita K, et al. Peroxynitrite inhibition ofcoxsackievirus infection by prevention of viral RNA entry. Proc Natl Acad Sci US A. 2004;101:11731–11736203. Pankuweit S, Hufnagel G, Eckhardt H, et al.
Cardiotropic DNA viruses andbacteria in the pathogenesis of dilated cardiomyopathy with or withoutinflammation. Med Klin 1998;93:223-228152204. Pankuweit S, Ruppert V, Eckhardt H et al. Pathophysiology and aetiologicaldiagnosis of nflammatory myocardial diseases with a special focus on parvovirusB19. J Vet Med B Infect Dis Vet Public Health. 2005; 52(7-8): р. 344-7205. Parrillo JE, Aretz HT, Palacios I et al. The results of transvenousendomyocardial biopsy can frequently be used to diagnose myocardial diseases inpatients with idiopathic heart failure. Endomyocardial biopsies in 100consecutive patients revealed a substantial incidence of myocarditis. Circulation1984;69:93-101206.Pauschinger M, Chandrasekharan K, Li J, Poller W, et al.
Inflammation andextracellular matrix protein metabolism: two sides of myocardial remodelling.Eur Heart J 2002; 4 (Suppl I):49–53207. Pei J, Li N, Chen J, Li X et al. The predictive values of beta1-adrenergic andM2 muscarinic receptor autoantibodies for sudden cardiac death in patients withchronic heart failure. Eur J Heart Fail. 2012; 14(8): р. 887-94208. Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated humanherpesvirus 6: questions and answers. Rev Med Virol. 2012;22:144–55.209. Peters AM, Osman S, Henderson BL, et al. Clinical experience with 99mTchexamethylpropyleneamineoximeforlabellingleukocytesandimaginginflammation.
Lancet.1986;8513:946–949210. Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings inmyocarditis. Am J Cardiol 1988;62:285-291211. Pohlner K, Portig I, Pankuweit S, et al. Identification of mitochondrial antigensrecognized by antibodies in sera of patients with idiopathic dilatedcardiomyopathy by two-dimensional gel electrophoresis and protein sequencing.Am J Cardiol 1997;80:1040-1045212.
Prystowsky EN, Padanilam BJ, Joshi S, Fogel RI. Ventricular arrhythmias inthe absence of structural heart disease. J Am Coll Cardiol 2012;59(20):1733-1744213. Ray CG, Icenogle TB, Minnich LL, et al. The use of intravenous ribavirin totreat influenza virus-associated acute myocarditis. J Infect Dis 1989;159:829-836153214. Rienstra M, Hagens VE, Van Veldhuisen DJ et al.















